广东
本文引用：罗培艺, 马良, 苟慎菊. 合并危险因素的高钾血症诊治进展[J]. 中国全科医学, DOI: 10.12114/j.issn.1007-9572.2022.0312.
LUO Peiy, MA Liang, GOU Shenju. Progress in diagnosis and treatment of hyperkalemia complicated with risk factors[J]. Chinese General Practice, DOI: 10.12114/j.issn.1007-9572.2022.0312.
摘要： 高钾血症是临床上的常见问题，发生的危险因素包括患有肾脏疾病、心血管疾病、糖尿病以及服用影响血钾的药物等。主要表现为心脏和神经肌肉症状，也可导致严重的心律失常。治疗上需以血钾水平和临床表现的严重程度为指导来选择药物或透析治疗。近年来涌现出多种新型口服降钾药物，有望改变高钾血症的治疗模式。本文结合文献，对合并危险因素的高钾血症的诊治进行综述。
关键词: 高钾血症, 危险因素, 诊断, 治疗
Abstract: Hyperkalemia is common in clinical settings. Numerous risk factors including kidney diseases, cardiovascular diseases, diabetes, drugs regulating blood potassium etc. may contribute to hyperkalemia. Generally, patients with hyperkalemia mainly suffer cardiac and neuromuscular symptoms, which subsequently lead to serious arrhythmia. The treatment should be performed according to the concentration of blood potassium and the severity of clinical manifestations. In recent years, a variety of new oral drugs to decrease potassium have emerged, which may alter the ways to contain hyperkalemia. This study reviewed the diagnosis and treatment of hyperkalemia combined with risk factors.
Key words: Hyperkalemia, Risk factors, Diagnosis, Treatment
合并危险因素的高钾血症诊治进展
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
